Souberbielle, J C; Body, J J; Lappe, J M; et al,; Bischoff-Ferrari, H A; von Landenberg, P (2010). Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmunity Reviews, 9(11):709-715.
Full text not available from this repository.
Recommendations were restricted to clinical practice and concern adult patients with or at risk for fractures, falls, cardiovascular or autoimmune diseases, and cancer. The panel reached substantial agreement about the need for vitamin D supplementation in specific groups of patients in these clinical areas and the need for assessing their 25-hydroxyvitamin D (25(OH)D) serum levels for optimal clinical care. A target range of at least 30 to 40 ng/mL was recommended. As response to treatment varies by environmental factors and starting levels of 25(OH)D, testing may be warranted after at least 3 months of supplementation. An assay measuring both 25(OH)D(2) and 25(OH)D(3) is recommended. Dark-skinned or veiled individuals not exposed much to the sun, elderly and institutionalized individuals may be supplemented (800 IU/day) without baseline testing.
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Rheumatology Clinic and Institute of Physical Medicine|
04 Faculty of Medicine > Center on Aging and Mobility
|DDC:||360 Social problems & social services|
610 Medicine & health
300 Social sciences, sociology & anthropology
|Deposited On:||31 Jan 2011 12:21|
|Last Modified:||27 Nov 2013 18:22|
|Citations:||Web of Science®. Times Cited: 147|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page